GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (NAS:NBTX) » Definitions » Other Stockholders Equity

NBTX (Nanobiotix) Other Stockholders Equity : $-0.00 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nanobiotix Other Stockholders Equity?

Nanobiotix's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $-0.00 Mil.

Nanobiotix's quarterly Other Stockholders Equity declined from Dec. 2023 ($0.00 Mil) to Jun. 2024 ($0.00 Mil) and declined from Jun. 2024 ($0.00 Mil) to Dec. 2024 ($-0.00 Mil).

Nanobiotix's annual Other Stockholders Equity declined from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) and declined from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($-0.00 Mil).


Nanobiotix Other Stockholders Equity Historical Data

The historical data trend for Nanobiotix's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanobiotix Other Stockholders Equity Chart

Nanobiotix Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nanobiotix Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nanobiotix Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Nanobiotix Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nanobiotix's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanobiotix Business Description

Traded in Other Exchanges
Address
60 Rue de Wattignies, Paris, FRA, 75012
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.